BMO Capital Downgrades Vitae Pharmaceuticals (VTAE) to Market Perform

September 15, 2016 7:10 AM EDT
Get Alerts VTAE Hot Sheet
Price: $21.00 --0%

Rating Summary:
    1 Buy, 5 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 28 | Down: 20 | New: 17
Trade VTAE Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

BMO Capital downgraded Vitae Pharmaceuticals (NASDAQ: VTAE) from Outperform to Market Perform with a price target of $21.00 (from $17.00).

For an analyst ratings summary and ratings history on Vitae Pharmaceuticals click here. For more ratings news on Vitae Pharmaceuticals click here.

Shares of Vitae Pharmaceuticals closed at $20.85 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

BMO Capital

Add Your Comment